–
Theravance Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−258
FY22:
−92.0
FY23:
−56.0
FY24:
−46.9
FY25:
−3.60
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
59.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−265
FY22:
−92.8
FY23:
−49.3
FY24:
−44.6
FY25:
129
(positive)
Change from FY21 to FY25
millions USD
FY21:
−199
FY22:
872
FY23:
−55.2
FY24:
−56.4
FY25:
106
All amounts in millions USD